Decades of LDT Tension Leads to an Epic Three-Hour Oral Argument
FDA Law
FEBRUARY 20, 2025
Given the numerous changes in policy by the Trump administration, there had been much speculation that the government would now take a different position on this Biden-era rule. In contrast, AMP and ACLA both asserted that the rule would harm medical care. The materials from this webinar are still available on FDAs website ( here ).
Let's personalize your content